UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate®

Screening for lipid disorders in adults

Author
Sandeep Vijan, MD
Section Editors
Mason W Freeman, MD
Joann G Elmore, MD, MPH
Deputy Editors
Howard Libman, MD
Gordon M Saperia, MD, FACC

INTRODUCTION

This topic addresses issues surrounding screening for lipid disorders in an adult primary prevention setting. The lipid profile and its components (total cholesterol, low density lipoprotein cholesterol, high density cholesterol, and triglycerides) are some of the most commonly ordered laboratory tests in clinical practice. The most common indication for this test (or its components) is for aiding the process of determining cardiovascular disease event risk. Other indications for these tests include the following:

Identifying patients who are at high risk for a lipid abnormality due to a family history of genetic disorder, such as familial hypercholesterolemia; this has been referred to as "reverse cascade screening." (See "Inherited disorders of LDL-cholesterol metabolism".)

Identifying the cause of another clinical problem such as pancreatitis.

Managing patients with established atherosclerotic cardiovascular disease.

Evaluating the efficacy of and/or adherence with lipid lowering therapy and lifestyle modification.

           

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jul 2017. | This topic last updated: Dec 14, 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2017 UpToDate, Inc.
References
Top
  1. Musunuru K. Atherogenic dyslipidemia: cardiovascular risk and dietary intervention. Lipids 2010; 45:907.
  2. Chou R, Dana T, Blazina I, et al. Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services Task Force. Ann Intern Med 2016; 165:560.
  3. http://www.who.int/gho/ncd/risk_factors/cholesterol_mean_text/en/ (Accessed on September 28, 2016).
  4. Silverman MG, Ference BA, Im K, et al. Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. JAMA 2016; 316:1289.
  5. Miller M, Stone NJ, Ballantyne C, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123:2292.
  6. D'Agostino RB Sr, Grundy S, Sullivan LM, et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001; 286:180.
  7. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease--the Framingham Heart Study. Can J Cardiol 1988; 4 Suppl A:5A.
  8. Arsenault BJ, Boekholdt SM, Kastelein JJ. Lipid parameters for measuring risk of cardiovascular disease. Nat Rev Cardiol 2011; 8:197.
  9. Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007; 298:776.
  10. Emerging Risk Factors Collaboration, Di Angelantonio E, Sarwar N, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993.
  11. Boekholdt SM, Arsenault BJ, Mora S, et al. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 2012; 307:1302.
  12. Carroll MD, Lacher DA, Sorlie PD, et al. Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005; 294:1773.
  13. Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129:S49.